scispace - formally typeset
M

Mark Unruh

Researcher at Cornell University

Publications -  309
Citations -  14789

Mark Unruh is an academic researcher from Cornell University. The author has contributed to research in topics: Kidney disease & Population. The author has an hindex of 53, co-authored 269 publications receiving 12617 citations. Previous affiliations of Mark Unruh include George Washington University & Harvard University.

Papers
More filters
Journal ArticleDOI

Psychosocial Impact of COVID-19 Pandemic on Patients with End-Stage Kidney Disease on Hemodialysis

TL;DR: This study provides preliminary insights into the psychosocial distress caused by the COVID-19 pandemic among a diverse cohort of patients receiving chronic HD who are participating in an ongoing clinical trial.
Journal ArticleDOI

Hospitalization event notifications and reductions in readmissions of Medicare fee-for-service beneficiaries in the Bronx, New York

TL;DR: In this article, the authors examined the effect of an event notification system on 30-day readmission in the Bronx, New York, and found that active hospitalization alert services were associated with a 2.9 percentage point reduction in the likelihood of readmission (95% confidence interval: −5.5, −0.4).
Journal ArticleDOI

Validation of a Core Patient-Reported Outcome Measure for Fatigue in Patients Receiving Hemodialysis: The SONG-HD Fatigue Instrument.

TL;DR: SONG-HD Fatigue seems to be a reliable and valid measure to be used in trials involving patients receiving hemodialysis, and demonstrated convergence with Functional Assessment of Chronic Illness Therapy-Fatigue and had moderate correlations with other measures that assessed related but not the same concept.
Journal ArticleDOI

Analysis of time to event outcomes in randomized controlled trials by generalized additive models.

TL;DR: By augmenting the HR conventionally reported, PGAMs have the potential to support the inferential goals of multiple stakeholders involved in the evaluation and appraisal of clinical trial results under proportional and non-proportional hazards.
Journal ArticleDOI

Trial of Amiloride in Type 2 Diabetes with Proteinuria.

TL;DR: Among patients with type 2 diabetes, normal renal function, and proteinuria, there were reductions in systolic blood pressure in groups treated with hydrochlorothiazide or amiloride.